Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
2018 · The Lancet HIV · 121 citations
https://doi.org/10.1016/s2352-3018(18)30071-7
C
Carlos A. DiazGranados
Gates Foundation(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
92
Papers
6.1K
Citations
32
h-index
54
i10-index
Carlos A. DiazGranados is an academic researcher from Gates Foundation. The author has contributed to research in topics: Influenza Virus Research Studies & Mosquito-borne diseases and control & HIV Research and Treatment. The author has an h-index of 32, co-authored 79 publications.
Papers by this author
worksSelection of HIV vaccine candidates for concurrent testing in an efficacy trial
2016 · Current Opinion in Virology · 14 citations
https://doi.org/10.1016/j.coviro.2016.01.007
Correlations between MN and PRNT<sub>50</sub> titers.
2020 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0234236.s001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat